Jing Li, Jinwei Li, Peiying Teng, Fan Yang, Jihong Zhang, Bo Sun and Wei Chen. Long noncoding RNA 1392 regulates MDA5 by interaction with ELAVL1 to inhibit coxsackievirus B5 infection[J]. Virologica Sinica, 2023, 38(5): 699-708. doi: 10.1016/j.virs.2023.08.001
Citation: Jing Li, Jinwei Li, Peiying Teng, Fan Yang, Jihong Zhang, Bo Sun, Wei Chen. Long noncoding RNA 1392 regulates MDA5 by interaction with ELAVL1 to inhibit coxsackievirus B5 infection .VIROLOGICA SINICA, 2023, 38(5) : 699-708.  http://dx.doi.org/10.1016/j.virs.2023.08.001

长链非编码RNA 1392(LINC1392)通过与ELAVL1相互作用调控MDA5而抑制柯萨奇病毒B5复制

  • 通讯作者: 陈伟, wchen@kust.edu.cn
  • 收稿日期: 2022-08-25
    录用日期: 2023-07-21
  • 长非编码RNAs(lncRNAs)可调节生物和病理过程的许多方面。最近的研究表明,宿主lncRNA参与抗病毒免疫反应,但在柯萨奇病毒B5(CVB5)感染后具有功能性的lncRNA仍然未知。在本研究中,我们鉴定了一种新的细胞质lncRNA(LINC1392)。LINC1392在CVB5感染的RD细胞中上调表达,并具有病毒感染时间和剂量的依赖性,同时可在病毒RNA和IFN-β诱导下表达。进一步研究表明,LINC1392通过激活MDA5,促进了包括IFIT1、IFIT2和IFITM3在内的多个重要干扰素刺激基因(ISGs)的表达,进而抑制CVB5复制。机制上,LINC1392与ELAVL1结合,阻断了ELAVL1与MDA5的相互作用。功能研究表明,LINC1392的245-835nt位点不仅发挥了抗病毒的主要作用,也是与ELAVL1结合的重要位点。在小鼠体内,LINC1392同样具有抗病毒作用,同时也改善了在病毒感染后肠道和脑组织的组织病变。我们的研究表明,LINC1392在针对CVB5感染引起的IFN-I信号通路中充当了正向调节因子。阐明宿主lncRNA调控抗病毒感染的固有免疫机制,进而为抗病毒药物研究奠定基础。

Long noncoding RNA 1392 regulates MDA5 by interaction with ELAVL1 to inhibit coxsackievirus B5 infection

  • Corresponding author: Wei Chen, wchen@kust.edu.cn
  • Received Date: 25 August 2022
    Accepted Date: 21 July 2023
  • Long noncoding RNAs (lncRNAs) modulate many aspects of biological and pathological processes. Recent studies have shown that host lncRNAs participate in the antiviral immune response, but functional lncRNAs in coxsackievirus B5 (CVB5) infection remain unknown. Here, we identified a novel cytoplasmic lncRNA, LINC1392, which was highly inducible in CVB5 infected RD cells in a time- and dose-dependent manner, and also can be induced by the viral RNA and IFN-β. Further investigation showed that LINC1392 promoted several important interferon-stimulated genes (ISGs) expression, including IFIT1, IFIT2, and IFITM3 by activating MDA5, thereby inhibiting the replication of CVB5 in vitro. Mechanistically, LINC1392 bound to ELAV like RNA binding protein 1 (ELAVL1) and blocked ELAVL1 interaction with MDA5. Functional study revealed that the 245-835 nt locus of LINC1392 exerted the antiviral effect and was also an important site for ELAVL1 binding. In mice, LINC1392 could inhibit CVB5 replication and alleviated the histopathological lesions of intestinal and brain tissues induced by viral infection. Our findings collectively reveal that the novel LINC1392 acts as a positive regulator in the IFN-I signaling pathway against CVB5 infection. Elucidating the underlying mechanisms on how lncRNA regulats the host innate immunity response towards CVB5 infection will lay the foundation for antiviral drug research.

  • 加载中
    1. Bardel E, Doucet-Ladeveze R, Mathieu C, Harandi AM, Dubois B, Kaiserlian D (2016) Intradermal immunisation using the TLR3-ligand Poly (I:C) as adjuvant induces mucosal antibody responses and protects against genital HSV-2 infection. NPJ Vaccines 1:16010

    2. Bonenfant G, Williams N, Netzband R, Schwarz MC, Evans MJ, Pager CT (2019) Zika Virus Subverts Stress Granules To Promote and Restrict Viral Gene Expression. J Virol 93:e00520-19

    3. Chai W, Li J, Shangguan Q, Liu Q, Li X, Qi D, Tong X, Liu W, Ye X (2018) Lnc-ISG20 Inhibits Influenza A Virus Replication by Enhancing ISG20 Expression. J Virol 92:e00539-18.

    4. Chen YG, Satpathy AT, Chang HY (2017) Gene regulation in the immune system by long noncoding RNAs. Nat Immunol 18:962-972

    5. Darnell JE Jr, Kerr IM, Stark GR (1994) Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. Science 264:1415-1421.

    6. Fu M, Zou C, Pan L, Liang W, Qian H, Xu W, Jiang P, Zhang X (2016) Long noncoding RNAs in digestive system cancers:Functional roles, molecular mechanisms, and clinical implications (Review). Oncol Rep 36:1207-1218

    7. Gao F, Bian L, Hao X, Hu Y, Yao X, Sun S, Chen P, Yang C, Du R, Li J, Zhu F, Mao Q, Liang, Z (2018) Seroepidemiology of coxsackievirus B5 in infants and children in Jiangsu province, China. Hum Vaccin Immunother 14:74-80

    8. Gao Q, Zhou R, Meng Y, Duan R, Wu L, Li R, Deng F, Lin C, Zhao L (2020) Long noncoding RNA CMPK2 promotes colorectal cancer progression by activating the FUBP3-c-Myc axis. Oncogene 39:3926-3938

    9. Ghafouri-Fard S, Poornajaf Y, Dashti F, Hussen BM, Taheri M, Jamali E (2022) Interaction Between Non-Coding RNAs and Interferons:With an Especial Focus on Type I Interferons. Front Immunol 13:877243

    10. Jehung JP, Kitamura T, Yanagawa-Matsuda A, Kuroshima T, Towfik A, Yasuda M, Sano H, Kitagawa Y, Minowa K, Shindoh M, Higashino F (2018) Adenovirus infection induces HuR relocalization to facilitate virus replication. Biochem Biophys Res Commun 495:1795-1800

    11. Jiang M, Zhang S, Yang Z, Lin H, Zhu J, Liu L, Wang W, Liu S, Liu W, Ma Y, Zhang L, Cao X (2018) Self-Recognition of an Inducible Host lncRNA by RIG-I Feedback Restricts Innate Immune Response. Cell 173:906-919.e913

    12. Kato H, Takeuchi O, Sato S, Yoneyama M, Yamamoto M, Matsui K, Uematsu S, Jung A, Kawai T, Ishii KJ, Yamaguchi O, Otsu K, Tsujimura T, Koh CS, Reis E Sousa C, Matsuura Y, Fujita T, Akira S (2006). Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses. Nature 441:101-105

    13. Liu R, Wu K, Li Y, Sun R, Li X (2020) Human antigen R:A potential therapeutic target for liver diseases. Pharmacol Res 155:104684

    14. Machado RS, Gomes-Neto F, Aguiar-Oliveira ML, Burlandy FM, Tavares FN, da Silva EE, Sousa IP Jr (2022) Analysis of Coxsackievirus B5 Infections in the Central Nervous System in Brazil:Insights into Molecular Epidemiology and Genetic Diversity. Viruses 14:899

    15. Mcnab F, Mayer-Barber K, Sher A, Wack A, O'garra A (2015) Type I interferons in infectious disease. Nat Rev Immunol 15:87-103

    16. Ouyang J, Zhu X, Chen Y, Wei H, Chen Q, Chi X, Qi B, Zhang L, Zhao Y, Gao GF, Wang G, Chen JL (2014) NRAV, a long noncoding RNA, modulates antiviral responses through suppression of interferon-stimulated gene transcription. Cell Host Microbe 16:616-626

    17. Palomo-Irigoyen M, Perez-Andres E, Iruarrizaga-Lejarreta M, Barreira-Manrique A, Tamayo-Caro M, Vila-Vecilla L, Moreno-Cugnon L, Beitia N, Medrano D, Fernandez-Ramos D, Lozano JJ, Okawa S, Lavin JL, Martin-Martin N, Sutherland JD, De Juan VG, Gonzalez-Lopez M, Macias-Camara N, Mosen-Ansorena D, Laraba L, Hanemann CO, Ercolano E, Parkinson DB, Schultz CW, Arauzo-Bravo MJ, Ascension AM, Gerovska D, Iribar H, Izeta A, Pytel P, Krastel P, Provenzani A, Seneci P, Carrasco RD, Del Sol A, Martinez-Chantar ML, Barrio R, Serra E, Lazaro C, Flanagan AM, Gorospe M, Ratner N, Aransay AM, Carracedo A, Varela-Rey M, Woodhoo A (2020) HuR/ELAVL1 drives malignant peripheral nerve sheath tumor growth and metastasis. J Clin Invest 130:3848-3864

    18. Posnakoglou L, Tatsi EB, Chatzichristou P, Siahanidou T, Kanaka-Gantenbein C, Syriopoulou V, Michos A (2021) Molecular Epidemiology of Enterovirus in Children with Central Nervous System Infections. Viruses 13:100

    19. Rothamel K, Arcos S, Kim B, Reasoner C, Lisy S, Mukherjee N, Ascano M (2021) ELAVL1 primarily couples mRNA stability with the 3' UTRs of interferon-stimulated genes. Cell Rep 35:109178

    20. Suarez B, Prats-Mari L, Unfried JP, Fortes P (2020) LncRNAs in the Type I Interferon Antiviral Response. Int J Mol Sci 21:6447

    21. Sui B, Chen D, Liu W, Wu Q, Tian B, Li Y, Hou J, Liu S, Xie J, Jiang H, Luo Z, Lv L, Huang F, Li R, Zhang C, Tian Y, Cui M, Zhou M, Chen H, Fu ZF, Zhang Y, Zhao L (2020) A novel antiviral lncRNA, EDAL, shields a T309 O-GlcNAcylation site to promote EZH2 lysosomal degradation. Genome Biol 21:228

    22. Teng P, Yang H, Li J, Yang F, Chen W (2022) Analysis of the long noncoding RNA profiles of RD and SH-SY5Y cells infected with coxsackievirus B5, using RNA sequencing. Arch Virol 167:367-376

    23. Tsuno K, Miyatake C, Nishijima H, Hotta C, Ogawa T, Asano T (2018) Coxsackievirus B5 Aseptic Meningitis in Infants in Chiba Prefecture, Japan, in 2016. J Nippon Med Sch 85:187-190

    24. Wang J, Guo Y, Chu H, Guan Y, Bi J, Wang B (2013) Multiple functions of the RNA-binding protein HuR in cancer progression, treatment responses and prognosis. Int J Mol Sci 14:10015-10041

    25. Wang J, Wang Y, Zhou R, Zhao J, Zhang Y, Yi D, Li Q, Zhou J, Guo F, Liang C, Li X, Cen S (2018) Host Long Noncoding RNA lncRNA-PAAN Regulates the Replication of Influenza A Virus. Viruses10:330

    26. Wang KC, Chang HY (2011) Molecular mechanisms of long noncoding RNAs. Mol Cell 43:904-914

    27. Wang Y, Wang P, Zhang Y, Xu J, Li Z, Li Z, Zhou Z, Liu L, Cao X (2020) Decreased Expression of the Host Long-Noncoding RNA-GM Facilitates Viral Escape by Inhibiting the Kinase activity TBK1 via S-glutathionylation. Immunity 53:1168-1181. e7

    28. Wu J, Chen ZJ (2014) Innate immune sensing and signaling of cytosolic nucleic acids. Annu Rev Immunol 32:461-488

    29. Xu J, Wang P, Li Z, Li Z, Han D, Wen M, Zhao Q, Zhang L, Ma Y, Liu W, Jiang M, Zhang X, Cao X (2021) IRF3-binding lncRNA-ISIR strengthens interferon production in viral infection and autoinflammation. Cell Rep 37:109926

    30. Yang P, Shi D, Fu J, Zhang L, Chen R, Zheng B, Wang X, Xu S, Zhu L, Wang K (2022) Atomic Structures of Coxsackievirus B5 Provide Key Information on Viral Evolution and Survival. J Virol 96:e0010522

    31. Yao Q, Xie Y, Xu D, Qu Z, Wu J, Zhou Y, Wei Y, Xiong H, Zhang XL (2022) Lnc-EST12, which is negatively regulated by mycobacterial EST12, suppresses antimycobacterial innate immunity through its interaction with FUBP3. Cell Mol Immunol 19:883-897

    32. Young LE, Sanduja S, Bemis-Standoli K, Pena EA, Price RL, Dixon DA(2009) The mRNA binding proteins HuR and tristetraprolin regulate cyclooxygenase 2 expression during colon carcinogenesis. Gastroenterology 136:1669-1679

    33. Yu X, Li Y, Ding Y, Zhang H, Ding N, Lu M (2020) HuR Promotes Ovarian Cancer Cell Proliferation by Regulating TIMM44 mRNA Stability. Cell Biochem Biophys 78:447-453

    34. Zhang Y, Cao X (2016) Long noncoding RNAs in innate immunity. Cell Mol Immunol 13:138-147

    35. Zhao L, Xia M, Wang K, Lai C, Fan H, Gu H, Yang P, Wang X (2020) A Long Non-coding RNA IVRPIE Promotes Host Antiviral Immune Responses Through Regulating Interferon beta1 and ISG Expression. Front Microbiol 11:260

  • 加载中
  • 10.1016j.virs.2023.08.001-ESM.docx

Article Metrics

Article views(1626) PDF downloads(19) Cited by(0)

Related
Proportional views
    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Long noncoding RNA 1392 regulates MDA5 by interaction with ELAVL1 to inhibit coxsackievirus B5 infection

      Corresponding author: Wei Chen, wchen@kust.edu.cn
    • Medical School, Kunming University of Science and Technology, Kunming, 650500, China

    Abstract: Long noncoding RNAs (lncRNAs) modulate many aspects of biological and pathological processes. Recent studies have shown that host lncRNAs participate in the antiviral immune response, but functional lncRNAs in coxsackievirus B5 (CVB5) infection remain unknown. Here, we identified a novel cytoplasmic lncRNA, LINC1392, which was highly inducible in CVB5 infected RD cells in a time- and dose-dependent manner, and also can be induced by the viral RNA and IFN-β. Further investigation showed that LINC1392 promoted several important interferon-stimulated genes (ISGs) expression, including IFIT1, IFIT2, and IFITM3 by activating MDA5, thereby inhibiting the replication of CVB5 in vitro. Mechanistically, LINC1392 bound to ELAV like RNA binding protein 1 (ELAVL1) and blocked ELAVL1 interaction with MDA5. Functional study revealed that the 245-835 nt locus of LINC1392 exerted the antiviral effect and was also an important site for ELAVL1 binding. In mice, LINC1392 could inhibit CVB5 replication and alleviated the histopathological lesions of intestinal and brain tissues induced by viral infection. Our findings collectively reveal that the novel LINC1392 acts as a positive regulator in the IFN-I signaling pathway against CVB5 infection. Elucidating the underlying mechanisms on how lncRNA regulats the host innate immunity response towards CVB5 infection will lay the foundation for antiviral drug research.

    Reference (35) Relative (20)

    目录

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return